Victory Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,406
| Closed | -$11.2K | – | 2576 |
|
|
2023
Q3 | $11.2K | Buy |
2,406
+80
| +3% | +$373 | ﹤0.01% | 2480 |
|
|
2023
Q2 | $12.5K | Sell |
2,326
-54
| -2% | -$289 | ﹤0.01% | 2477 |
|
|
2023
Q1 | $23.4K | Buy |
2,380
+68
| +3% | +$669 | ﹤0.01% | 2499 |
|
|
2022
Q4 | $43.3K | Sell |
2,312
-1
| -0% | -$19 | ﹤0.01% | 2466 |
|
|
2022
Q3 | $48K | Sell |
2,313
-181
| -7% | -$3.76K | ﹤0.01% | 2571 |
|
|
2022
Q2 | $52K | Buy |
2,494
+188
| +8% | +$3.92K | ﹤0.01% | 2549 |
|
|
2022
Q1 | $76K | Sell |
2,306
-66
| -3% | -$2.18K | ﹤0.01% | 2553 |
|
|
2021
Q4 | $142K | Sell |
2,372
-73
| -3% | -$4.37K | ﹤0.01% | 2529 |
|
|
2021
Q3 | $210K | Sell |
2,445
-99
| -4% | -$8.5K | ﹤0.01% | 2509 |
|
|
2021
Q2 | $283K | Sell |
2,544
-98
| -4% | -$10.9K | ﹤0.01% | 2436 |
|
|
2021
Q1 | $294K | Sell |
2,642
-652
| -20% | -$72.6K | ﹤0.01% | 2406 |
|
|
2020
Q4 | $350K | Sell |
3,294
-741
| -18% | -$78.7K | ﹤0.01% | 2226 |
|
|
2020
Q3 | $562K | Buy |
4,035
+1,023
| +34% | +$142K | ﹤0.01% | 1912 |
|
|
2020
Q2 | $974K | Sell |
3,012
-734
| -20% | -$237K | ﹤0.01% | 1745 |
|
|
2020
Q1 | $334K | Buy |
3,746
+650
| +21% | +$58K | ﹤0.01% | 2214 |
|
|
2019
Q4 | $123K | Buy |
3,096
+1,728
| +126% | +$68.7K | ﹤0.01% | 2476 |
|
|
2019
Q3 | $34K | Buy |
+1,368
| New | +$34K | ﹤0.01% | 2852 |
|